Mestag Therapeutics, a Cambridge, UK-headquartered biotech company working on new insights into fibroblast-immune interactions, has signed a license and collaboration...
- Sirhamnose from Exsymol is an innovative active ingredient that protects the dermal-epidermal junction (DEJ) and provides it with new stability. It is now available as part of...
